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Stimulation-induced increases of astrocytic oxidative metabolism
in rats and humans investigated with 1-11C-acetate
Abstract
The purpose of this study was to investigate astrocytic oxidative metabolism using 1-(11)C-acetate.
1-(11)C-acetate kinetics were evaluated in the rat somatosensory cortex using a beta-scintillator during
different manipulations (test-retest, infraorbital nerve stimulation, and administration of acetazolamide
or dichloroacetate). In humans a visual activation paradigm was used and kinetics were measured with
positron emission tomography. Data were analyzed using a one-tissue compartment model. The
following features supported the hypothesis that washout of radiolabel (k(2)) is because of (11)C-CO(2)
and therefore related to oxygen consumption (CMRO(2)): (1) the onset of (11)C washout was delayed;
(2)k(2) was not affected by acetazolamide-induced blood flow increase; (3)k(2) demonstrated a
significant increase during stimulation in rats (from 0.014+/-0.007 to 0.027+/-0.006 per minute) and
humans (from 0.016+/-0.010 to 0.026+/-0.006 per minute); and (4) dichloroacetate led to a substantial
decrease of k(2). In the test-retest experiments K(1) and k(2) were very stable. In summary,
1-(11)C-acetate seems a promising tracer to investigate astrocytic oxidative metabolism in vivo. If the
washout rate indeed represents the production of (11)C-CO(2), then its increase during stimulation
would point to a substantially higher astrocytic oxidative metabolism during brain activation. However,
the quantitative relationship between k(2) and CMRO(2) needs to be determined in future experiments.
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Abstract 
The purpose of this study was to investigate astrocytic oxidative metabolism using 1-11C-
acetate. 1-11C-acetate kinetics were evaluated in the rat somatosensory cortex using a beta 
scintillator during different manipulations (test-retest, infraorbital nerve stimulation and 
administration of acetazolamide or dichloroacetate). In humans a visual activation paradigm 
was used and kinetics were measured with positron emission tomography. Data were 
analyzed using a one-tissue compartment model. The following features supported the 
hypothesis that washout of radiolabel (k2) is due to 11C-CO2 and therefore related to oxygen 
consumption (CMRO2): 1) the onset of 11C washout was delayed; 2) k2 was not affected by 
acetazolamide-induced blood flow increase; 3) k2 demonstrated a significant increase during 
stimulation in rats (from 0.014±0.007 to 0.027±0.006min-1) and humans (from 0.016±0.010 to 
0.026±0.006min-1) and 4) dichloroacetate led to a substantial decrease of k2. In the test-
retest experiments K1 and k2 were very stable.  
In summary, 1-11C-acetate seems a promising tracer to investigate astrocytic oxidative 
metabolism in vivo. If the washout rate is indeed representing the production of 11C-CO2, 
then its increase during stimulation would point to a substantially higher astrocytic oxidative 
metabolism during brain activation. However, the quantitative relationship between k2 and 
CMRO2 needs to be determined in future experiments. 
 
Key words: 1-11C-acetate, astrocytes, beta scintillator, oxidative metabolism, positron 
emission tomography, washout 
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Introduction 
There is increasing evidence that astrocytes and neurons constitute a tightly coupled 
metabolic unit. Already early studies of brain metabolism using 14C-labeled precursors such 
as glucose or acetate led to the concept of two distinct tricarboxylic acid (TCA) cycle 
compartments, i.e. two separate pools for glutamate and glutamine (Berl and Frigyesi 1969; 
Cremer 1970; Minchin and Beart 1975; Van den Berg et al. 1969). Later histochemical work 
on the restricted localization of glutamine synthetase to glial cells (Martinez-Hernandez et al. 
1977; Norenberg and Martinez-Hernandez 1979) further supported the idea on the glial and 
neuronal site of these distinct pools. Simplification of these data has sometimes led to the 
wrong assumption that the oxidative activity of astrocytes is negligible. However, studies 
using mainly NMR spectroscopy have suggested that astrocytic energy metabolism indeed 
contains a substantial oxidative component which may account for up to 30% of total 
oxidative metabolism in brain under resting conditions (for review see (Hertz and Kala 2007; 
Hertz et al. 2007; Hyder et al. 2006). Recent transcriptome analysis has revealed a pattern of 
gene expression in astrocytes consistent with a significant oxidative activity (Lovatt et al. 
2007). 
Another question is how astrocytic metabolism behaves during activation. A recent study 
using ex vivo autoradiography with 14C labeled acetate at the carbon 2 position suggested 
that astrocytic oxidative metabolism increases with brain activity (Cruz et al. 2005). Labeled 
acetate is a promising candidate to investigate astrocytic oxidative metabolism in vivo 
because it is selectively taken up and metabolized by astrocytes (Hassel et al. 1992; Muir et 
al. 1986; Waniewski and Martin 1998). Earlier studies in the heart muscle have further 
revealed that quantitative measures for oxygen consumption can be derived from the 
washout rate of label after injection of radiolabeled acetate (Buck et al. 1991). Acetate can be 
labeled in the 1- or 2-carbon position. Whole body studies using 13C labeled acetate 
demonstrated that labeled CO2 is produced during the second or third turn in the TCA cycle, 
depending on whether 1-13C-acetate or 2-13C-acetate was used (Wolfe and Jahoor 1990). 
However, these results reflect whole body metabolism, brain-specific reactions cannot be 
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directly derived from them. In brain, with 1- and 2-labeled acetate there was substantial 
labeling of amino acids, such as glutamate, glutamine and aspartate and further TCA cycle 
intermediates as shown in older and more recent literature (Badar-Goffer et al. 1990; Berl 
and Frigyesi 1969; Lebon et al. 2002; Tyce et al. 1981; Tyson et al. 2003; Van den Berg et 
al. 1969; Van den Berg and Ronda 1976). However, the static measurement of metabolites 
at single time points yields only limited information on astrocytic oxidative metabolism.  
In this study we applied 1-11C-acetate and dynamic measurements to investigate astrocytic 
oxidative metabolism. Specific questions were: 1) what is the extraction fraction of the tracer, 
2) what is the kinetic behavior at baseline and during stimulation and 3) how does 
dichloroacetate, an agent that increases the production of acetyl-CoA from pyruvate in the 
cell, change the kinetics of 1-11C-acetate and 4) is the loss of radiolabel dependent on blood 
flow. Studies were performed in rats and humans. In rats data were acquired using a beta 
scintillator, in humans we applied positron emission tomography.  
 
 
Material and Methods 
Automated radiosynthesis of sodium 1-11C-acetate   
11C-CO2 was produced by the 14N(p,α)11C nuclear reaction using a nitrogen gas (N2/0.5%O2) 
target. 11C-CO2 was bubbled at room temperature in a mixture of methylmagnesium bromide 
(3M solution in diethyl ether; Fluka, 70 µl, 0.21 mmol) and dry diethyl ether (3 mL) placed in 
the reactor, where the chemical trapping of the 11C-CO2 by C-carboxylation of the Grignard 
reagent takes place instantly. After delivery (10 min) the reaction was quenched by 
automated addition of nearly equimolar amount of acid (1 mL 0.2M aqueous HCl, 0.2 mmol 
HCl) and the diethyl ether from the bilayer mixture was removed by evaporation in a stream 
of nitrogen (100 mL/min) for about 10 min. The residual water solution of 1-11C-acetic acid 
was automatically drawn into the loop of the preparative chromatograph (Merck-Hitachi 
chromatograph equipped with L-4000A UV detector at 254 nm, isocratic pump L-6000A, 5 
mL loop, and radiation detector Radiation Monitor, Eberline Instrument Corporation, Santa 
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Fe, New Mexico), injected into a semipreparative reversed phase column (Polymerx, 10 µm, 
250 x 10 mm, Phenomenex) and eluted with a mixture of sterile salt physiologic solution as 
the mobile phase. The fraction corresponding to the 1-11C-acetic acid (tR = 7 min) was 
collected  to give up to 10 GBq activity of no-carrier-added sodium 1-11C-acetate with over 
99% radiochemical purity and specific activity of about 400 GBq/µmol at the end of the 
synthesis in 10 mL sterile isotonic, buffered at physiological pH solution. The radiolabeling 
was performed in a lead shielded cell using a computer assisted homemade automatic 
apparatus controlled by LabVIEW software (National Instruments) via Modulink and RS232 
interfaces.  
 
Radiotracer experiments 
Experiments were performed in animals using the beta scintillator and in humans using 
positron emission tomography (PET). All animal experiments were approved by the local 
veterinary authorities and were carried out in accordance with their guidelines. The 
experiments were performed by licensed investigators. The animals were kept in cages in a 
ventilated cabinet with standardized conditions of light (night/day-cycle 12h/12h) and 
temperature and free access to food and water. Before the experiment the animals were 
fasted overnight. 29 Sprague-Dawley rats (5 for the extraction fraction determination, 24 for 
the different experimental paradigms (for details see below) weighing 310 ± 41 g (mean ± 
standard deviation) were included in the study. 
The human study population was composed of six healthy male volunteers aged between 24 
and 36 yrs without any known neurological impairments. All subjects were studied at the 
University Hospital Zurich. Informed written consent was obtained from all subjects before 
the beginning of the experiment. The protocol was approved by the local Ethics committee. 
MR scanning was performed on each subject (Twin Speed, GE Medical systems, Milwaukee, 
USA) to rule out any cerebral pathologies and for anatomical coregistration of the PET scan.  
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Animal preparation 
Surgery was performed under isoflurane anesthesia and involved the placement of an 
arteriovenous (a-v) shunt from the right femoral artery to the right femoral vein, tracheotomy 
for mechanical ventilation and exposition of the skull with subsequent thinning of the bone 
above the primary somatosensory cortex using a dental drill. The actual experiment was then 
performed under urethane anesthesia (1400 mg/kg i.p.). The a-v shunt was used for the 
injection of the tracer, for collecting blood samples for metabolite analysis, for the monitoring 
of arterial blood pressure and for the continuous measurement of total arterial 11C activity. 
For the latter purpose, the shunt was run through a coincidence counter (GE Medical 
Systems) that stored the whole blood radioactivity concentration at 1-second intervals. The 
online arterial sampling procedure is described in detail elsewhere (Weber et al. 2002).  
 
Beta scintillator  
The beta scintillator (Swisstrace, Zurich, Switzerland) has been described in detail earlier 
(Weber et al. 2003; Wyss et al. 2007). In short, it consists of a scintillation tip (Bicron, BF12, 
Newbury, OH, USA) with a length of 1 mm and a diameter of 0.25 mm attached to a high 
numerical aperture glass fiber. The scintillator was made light-tight by applying a uniform 
coating of silver particles. The scintillations were measured using a photomultiplier tube and 
counting electronics (Perkin Elmer, Massachusetts, USA). The limited range of beta particles 
within biological tissues leads to a limited detection volume centered around the scintillating 
tip of the probe. Monte Carlo simulations demonstrated that for C-11 the distance required to 
detect 90 % of the beta particles around the probe is 2.0 mm (Pain et al. 2002). The 
sensitivity of the used beta scintillator was in the range of 0.036 to 0.047 cps/kBq/cc. 
The scintillator was inserted into the cortex using a stereotactic frame (David Kopf 
Instruments, Tujunga, CA, USA). At the insertion point, which was about (according to 
Bregma) 1 mm posterior and 5 mm lateral, the thinned bone was removed and the dura was 
carefully incised. The scintillator tip was lowered 1.4 mm below the dura. In the stimulation 
experiments, the correct position was verified by Laser Doppler flowmetry (Periflux System 
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5000, Perimed AB, Järfälla, Sweden). This position was adjusted to avoid large superficial 
blood vessels. Only one scintillator penetration was performed per animal. The count rate 
was stored on a personal computer using a bin width of 1 second yielding tissue time activity 
curves . 
 
Positron emission tomography 
All subjects were scanned on a whole-body Positron emission tomography/ 
Computertomography-scanner (Discovery ST-RX; GE Medical Systems, Waukesha, USA). 
This is a scanner with an axial field of view of 14.6 cm and a reconstructed in-plane 
resolution of about 7 mm. Before the positioning of the subjects in the scanner, a radial artery 
was cannulated for timed arterial blood sampling. An additional catheter for administration of 
the radiotracers was placed in the contralateral antecubital vein. At the beginning of each 
study, a low dose computer tomogram for attenuation correction was performed. 
 
 
Experimental protocols 
a) Cerebral blood flow measurements using H215O - First pass extraction fraction 
The first pass extraction fraction (EF) of 1-11C-acetate at baseline was determined according 
to the relationship EF = K1/CBF, where K1 is the transport parameter of the one-tissue 
compartment model and CBF is cerebral blood flow. CBF was determined in 5 animals using 
15O labeled water injected prior to measurement of 1-11C-acetate kinetics. In the human study 
CBF was measured in all subjects 10 minutes before the 1-11C-acetate injections. The visual 
stimulation was interrupted between CBF and acetate measurements. Approximately 300 
MBq H215O were injected intravenously using an automatic injection device. Following the 
arrival of the bolus in the brain, the acquisition of a series of 18 frames (10 s each frame) 
was started.  
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b) Measurements of 1-11C-acetate kinetics during different conditions 
In the animal experiments two injections spaced 30 minutes apart were performed. Data 
were acquired for 20 minutes after the injection (slow injection over a period of 30 seconds) 
of 230-260 MBq (diluted in 0.5 mL) of radiotracer. This part of the study included 24 animals, 
which were distributed among the following experimental subgroups: l) in this group the 
baseline was followed by electrostimulation (bas-stim); ll) the order was reversed (stim-bas). 
Groups I) and II) were examined with respect to a potential order effect. lll) To evaluate the 
reproducibility two consecutive baseline measurements were performed (bas-bas). IV) In four 
animals the effect of acetazolamide (Diamox®, 66 mg/kg), a carbonic anhydrase inhibitor 
increasing CBF but not oxygen consumption (CMRO2; (Okazawa et al. 2001)), on the 
kinetics of 1-11C-acetate was examined. After 20 minutes of baseline acquisition, 
acetazolamide was intravenously injected over one minute. Ten minutes later the same 
amount of 1-11C-acetate was injected for the second time. In a last group (V) the effect of 
dichloroacetate was investigated. Four hours after the injection of dichloroacetate (50 mg/kg, 
Sigma-Aldrich Prod. No. 347795) a baseline study was followed by electrostimulation 
(dichloroacetate challenge). Dichloroacetate was dissolved in physiological saline and was 
adjusted to pH 7.4. 
To activate the whisker-to-barrel pathway the infraorbital branch of the trigeminal nerve was 
electrically stimulated with two stainless steel electrodes. The cathode was inserted through 
the infraorbital hiatus and the anode was positioned in the masticatory muscle on the 
ipsilateral side. The current was adjusted to 2 mA and 2 Hz stimulation frequency was 
chosen because previous measurements using 18F-fluorodeoxyglucose-autoradiographies 
demonstrated this frequency to be optimal eliciting a maximal increase in glucose 
consumption of 70 to 80 % (unpublished data). The stimulation started 30 seconds before 
the tracer injections. To check the effectivity of the applied stimulation and the effect of 
acetazolamide in group IV) animals, a Laser Doppler flowmetry probe was fixed just above 
the primary somatosensory cortex to follow regional cerebral blood flow (rCBF) changes.  
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In humans PET was performed under baseline conditions with eyes closed and during visual 
stimulation using different video clips presented on a screen (Charlie’s angels & Rolling 
stones). In three subjects the baseline examinations were preceding the stimulation studies 
and in the other three subjects the order was reversed to rule out any order effect. The visual 
stimulation was started 20 seconds before scan start and continued during complete PET 
acquisition. After the intravenous injection of 250 MBq 1-11C-acetate administered as a slow 
bolus over approximately 60 s data were recorded for 20 minutes (25 frames: 6 x 20 s, 3 x 40 
s and 16 x 60 s).  
Time activity curves were derived from volumes of interest defined on three consecutive 
slices on the anatomical MR scans and subsequently transferred to the PET data. Volumes 
of interest were drawn in the visual cortex as the target region and in the frontal cortex and 
cerebellum as references.  
 
Statistics 
The Wilcoxon Signed Rank test for dependent samples was used to evaluate differences 
between within-subject conditions and the Mann Whitney U test was used for group 
differences. The criterion for significance was set at p < 0.05. Values are expressed as mean 
± sd. 
 
 
Data acquisition and analysis 
 
The details are described in the appendix. 
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Results 
A. Animal studies 
Metabolites of 1- 11C-acetate in the blood  
HPLC identified 11C-CO2 as the only metabolite in blood. The time course of the fraction of 
authentic 11C-acetate in arterial plasma is demonstrated in Figure 1. The pH and arterial 
blood gases were all in the physiological range (pH = 7.35 – 7.45; pCO2 = 35 – 45 mmHg; 
pO2 = 70 – 100 mmHg). Plasma lactate levels were also determined as lactate competes 
with acetate for the uptake into brain.  They ranged between 1.4 and 2.1 mmol/L. However, 
no relationship between plasma lactate levels and changes in the kinetics of 1-11C-acetate 
could be found. Only in group V (dichloroacetate challenge) there was a statistically 
significant difference in plasma levels between the two different modalities (see below).  
 
First pass extraction fraction.  
CBF was measured in 5 baseline experiments and was 56 ± 16 ml/min/100g. The first pass 
extraction fraction of 1-11C-acetate calculated in these experiments was 18 ± 5 %.  
 
Reproducibility of the 1-11C-acetate measurements  
The reproducibility of the time activity curves and of the parameters K1 and k2 is 
demonstrated in the top graphs of Figure 2 and 3. In contrast to trigeminal nerve stimulation, 
the tissue time activity curves in the 2 sequential baseline experiments look identical. The 
difference of the mean K1 (K1experiment2 - K1experiment1 ) was –0.001, and for k2 the difference was 
0.002 min-1. 
 
1-11C-acetate kinetics during infraorbital nerve stimulation 
The electrical infraorbital nerve stimulation increased the washout of 1-11C-acetate as shown 
in the middle graph of Figure 2. The order of the experiments (baseline-stimulation or 
stimulation-baseline) had no significant effect on the changes of the kinetic parameters 
(Figure 3C and 3D). Therefore the two groups l) and ll) (bas-stim and stim-bas) were pooled. 
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During stimulation, k2 increased by 93 % from 0.014 ± 0.007 to 0.027 ± 0.006 min-1 (p < 0.01) 
in the primary somatosensory cortex. In parallel, K1 increased from 0.080 ± 0.015 at baseline 
to 0.095 ± 0.017 (p < 0.01). The efficacy of the stimulation was confirmed by the increase of 
the laser Doppler flowmetry signal by 20 – 25 % (data not shown).  
To check for a delayed onset of the radioactivity washout, the first 5 minutes of data were 
refitted with only k2 as a free parameter. In this data set k2 decreased from 0.014.± 0.007 to 
0.001 ± 0.002 in the baseline experiments and from 0.027 ± 0.006 to 0.003 ± 0.004 in the 
stimulation experiments. An example of a 5 minute fit is illustrated at the bottom of Figure 2. 
The low k2 of 0.001 fits the initial data well, then the washout is clearly increased.  
 
Effect of acetazolamide on k2 
In the 4 experiments k2 was 0.016 ± 0.002 at baseline and 0.016 ± 0.002 min-1 10 minutes 
following acetazolamide injection. Laser Doppler flowmetry showed a signal increase of 61.1 
± 8.1 %. 
 
Effect of dichloroacetate on k2 during baseline and stimulation  
Dichloroacetate pretreatment lowered arterial plasma lactate from 1.5 ± 0.1 to 1.25 ± 0.2 
mmol/L (mean ± sd; p < 0.05) but exerted no change of arterial blood gases which stayed in 
the physiological range. Four hours after intravenous dichloroacetate administration, k2 was 
lower at baseline and during stimulation, compared to the experiments without 
dichloroacetate. At baseline the values were on average 36% lower (0.009 ± 0.002 
compared to 0.014 ± 0.007), however, this difference failed to reach significance (n = 5; p = 
0.15). During stimulation k2 was 26% lower (n = 5; p < 0.05) than in the experiments without 
administration of dichloroacetate (0.020 ± 0.004 compared to 0.027 ± 0.006). There was still 
a significant 122 % increase of k2 from baseline to electrostimulation (from 0.009 ± 0.002 to 
0.020 ± 0.004; n = 5; p < 0.05; Figure 3E) 
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Relationship of the tissue activity and changes of the washout rate k2
This relationship is a measure of the parameter identifiability. A larger change of the tissue 
activity with a unit change of k2 is associated with a better parameter identifiability. The 
sensitivity analysis demonstrated that at 20 minutes, a 10 percent change in k2 led to a 2.1 
percent change in tissue activity at baseline (k2 = 0.014 min-1) and to a 3.8 percent change 
during stimulation (k2  = 0.027min-1). Furthermore, the activity change in tissue was linear in 
the investigated range 0 – 30 % k2 change.  
 
 
B. Human studies 
1-11C-acetate kinetics present the same characteristics as in animal studies 
In all subjects the blood gas parameters were always in the physiological range (pH = 7.35 – 
7.45; pCO2 = 35 – 45 mmHg; pO2 = 70 – 100 mmHg). An illustration of the effect of the visual 
activation on the kinetic of 1-11C-acetate is demonstrated in Figure 4 and the quantitative 
values are shown in Figure 5. The calculated EF of 1-11C-acetate in visual cortex was 19 ± 4 
% at baseline and 13 ± 3 % during stimulation. The visual stimulation increased mean CBF in 
visual cortex by 64 % (p < 0.05). In the control regions ‘cerebellum’ and ‘frontal cortex’ no 
significant change of the CBF was noticed. In visual cortex mean K1 and k2 values of 1-11C-
acetate were 11 % and 62 % (p < 0.05 for both) higher during stimulation as shown in 
Figures 5F and 5I. No significant changes of K1 or k2 were noted in frontal cortex and 
cerebellum. However, in frontal cortex K1 and k2 data are somewhat distorted by a single 
subject which showed a decrease of the values in this region in response to visual 
stimulation. 
.  
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Discussion 
It was previously suggested that the astrocyte-specific substrate acetate allows to measure 
metabolism in human brains in vivo (Hosoi et al. 2004; Muir et al. 1986). However, to our 
knowledge this is the first study using label clearance from brain after 1-11C-acetate 
administration for the investigation of astrocytic oxidative metabolism in vivo. Labeled acetate 
was already used in various studies to illuminate certain aspects of astrocytic metabolism. 
Some groups used autoradiographical determination of 14C-acetate uptake (Cruz et al. 2005; 
Muir et al. 1986), other groups measured the metabolic fate of acetate by measuring the 
appearance of labeled compounds as the label travelled through the TCA cycle (e,g, (Badar-
Goffer et al. 1990; Berl and Frigyesi 1969; Lebon et al. 2002; Van den Berg and Ronda 
1976). 
Our study demonstrates for the first time changes of 1-11C-acetate kinetics during stimulation 
in vivo which are thought to be correlated with changes of astrocytic oxidative metabolism. 
While total cerebral CMRO2 can be successfully measured in vivo using PET and inhaled 
15O2 (Mintun et al. 1984; Yee et al. 2006), a direct in vivo measurement of CMRO2 in 
astrocytes alone is not available.  
 
K1 and extraction fraction 
Compared to the heart where 1-11C-acetate is almost 100% extracted, the cerebral extraction 
fraction is about 5-fold lower. Nevertheless, brain uptake is large enough to allow 
quantification. One consequence of the lower extraction fraction is the blunted increase of K1 
compared to CBF during stimulation. In the human study K1 increased 11 % compared to a 
64 % increase in CBF (visual cortex).  
 
Quantitative relationship between k2 and astrocytic CMRO2  
In the following discussion about the meaning of the rate constant k2 we provide arguments 
that k2 may be strongly related to CMRO2. However, it is clear that a direct proof is not given 
and would be difficult to establish as there is actually no data available to prove this 
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conclusion directly. One major reason is that a direct measurement of astrocytic CMRO2 is 
yet impossible in vivo.  
We hypothesize that k2 is directly related to CMRO2 in the astrocytes as has been 
demonstrated in the heart for the myocytes (Buck et al. 1991). Prerequisites for this 
hypothesis are a) the washout of radioactivity from the volume of interest is indeed due to the 
loss of 11C-CO2 and b) the rate limiting step determining k2 is the production of 11C-CO2 and 
not its removal. 
 
Prerequisite a) 
There seems to be no doubt that at least part of the radioactivity loss is due to 11C-CO2, since 
the production of labeled CO2 from exogenous 1-14C-acetate has been proven in astrocyte 
cultures (Waniewski and Martin 1998). However, a quantitative proof of prerequisite a) would 
be difficult. One theoretical possibility would be the measurement of the arterio-venous (a-v) 
difference of 11C-CO2. However, a first order estimation of this difference demonstrates that it 
would be in the order of 4 % of the total blood counts. The conclusive demonstration of such 
a small difference would require a prohibitively large amount of animals.  
Prerequisite b)  
It is well known that CO2 diffuses practically freely across the blood brain barrier (Paulson 
2002). It could therefore theoretically be possible that the removal of CO2 by the blood is a 
limiting factor for the washout of CO2. However, the lack of a change of k2 following the 
acetazolamide-induced blood flow increases demonstrates that the removal of the 
radioactivity from the volume of interest is not a limiting factor.   
Other arguments which point at a strong relationship between k2 and astrocytic CMRO2 are: 
1) the increase of k2 during stimulation, 2) the delay of the onset of the label washout and the 
decrease of the K1/k2 ratio during stimulation 3) the behavior of k2 under dichloroacetate and 
4) reasonable values of astrocytic CMRO2 can be obtained by applying the calibration 
established in the dog heart.  
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Changes of k2 during increased brain activity 
Parameter k2 significantly increased during stimulation. In the animal study, k2 almost 
doubled from baseline to infraorbital nerve stimulation, indicating a substantial increase in 
oxygen consumption. In the human study the increase in the visual cortex was 63 %. 
Although not significant there also seemed to be a trend towards higher values in cerebellum 
and frontal cortex. In fact, omitting the subject with a lower value during stimulation, the 
increase became significant, not surprising considering the connectivity in the brain.  
 
Delay of the washout onset and the decrease of the K1/k2 ratio during stimulation 
Another result pointing at 11C-CO2 as the washout agent is the delay of the washout onset 
(bottom graph of Figure 2). Such a delay for the appearance of labeled CO2 was 
demonstrated by Waniewski and Martin in cultured astrocytes and is explained by the fact 
that labeled CO2 is only produced in the second turn of the label in the TCA cycle (Waniewski 
and Martin 1998). If the loss of label was substantially due to backdiffusion of labeled 
acetate, one would not expect a delay. Furthermore, if backdiffusion of labeled acetate was 
the main factor determining k2, one would expect the same effect of stimulation on K1 and k2, 
i.e. the ratio K1/k2 would remain constant. However, the data demonstrate a markedly lower 
ratio during stimulation. In the anesthetized rat studies, the mean ratio dropped 44 % 
(p=0.08), in the studies with dichloroacetate the decrease was 53 % (p=0.001) and in the 
human visual cortex the ratio dropped 44 % (p=0.048). This behavior suggests that the 
labeled compounds entering and leaving the brain tissue are different. The mentioned points 
are all consistent with the hypothesis that the washed out compound is indeed 11C-CO2. 
However, we cannot completely exclude that some label loss is due to release of other 
labeled substrates, particularly due to efflux of glutamine, which is quickly labeled after 
injection of radiolabeled acetate (Cremer 1970). Despite the fact that the blood brain barrier 
is closed for the passage of glutamate and glutamine from blood to brain the reverse 
direction seems possible. Glutamine is taken up by endothelial cells and intracellularly 
converted by the enzyme glutaminase to glutamate. When the glutamate concentration 
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within endothelial exceeds the one in plasma net transport of glutamate takes place through 
facilitative transporters (Hawkins et al. 2006). The high number of steps involved in this 
process and the fact that normal plasma concentration of glutamate is about 10 times higher 
than glutamate concentration in the extracellular fluid of the brain (Hawkins et al. 2006) 
indicate that this process is slow and probably not of relevance during our acquisition period 
of 20 minutes. 
. 
 
Pharmacological interventions using dichloroacetate and acetazolamide. 
Also the dichloroacetate experiments are consistent with the hypothesis that k2 is related to 
CMRO2. This compound activates pyruvate dehydrogenase (Abemayor et al. 1984) by 
inhibiting its phosphorylation by the PDH kinase (Whitehouse et al. 1974). As a consequence 
more pyruvate is converted to acetyl-CoA and less to lactate and the concentration of acetyl-
CoA is expected to increase. If the rate constants in the following chain of acetyl-CoA 
oxidation, which are expected to be related to k2, remained the same, the rate of the acetyl-
CoA metabolism would increase and with it most likely CMRO2.  However, since the 
energetic demand is unchanged there is no reason why CMRO2 should increase. 
Consequently one would expect a decrease in k2 and this is exactly what was observed, at 
baseline as well as during stimulation. A good candidate for regulation at this stage is citrate 
synthase which condenses acetyl-CoA and oxaloacetate into citrate. It has been documented 
that this enzyme is inhibited by increased concentrations of acetyl-CoA (Bayer et al. 1981). 
This inhibition could be a major reason for the observed decrease of k2 following 
dichloroacetate. Furthermore, the suggested increase of the cold acetyl-CoA concentration 
under dichloroacetate is itself indirect evidence for the ability of astrocytes to completely 
oxidize glucose, as is the work by Lovatt et al. which confirmed significantly higher relative 
expression of almost all TCA cycles enzymes in freshly isolated astrocytes than neurons and 
showed that the oxidative pathways were active in astrocytes (Lovatt et al. 2007). 
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Analogy with previous heart studies 
The idea to use the washout rate k2 of 1-11C-acetate as a marker of CMRO2 was inspired by 
earlier studies performed in the heart (Armbrecht et al. 1990; Buck et al. 1991; Lindner et al. 
2006). In those studies it was clearly established that k2 reflects myocardial oxygen 
consumption in a linear fashion. One rough indication that this approach may be also valid in 
the brain is derived from the following estimation. In the dog heart the relationship between 
CMRO2 and k2 was CMRO2 [mL/min/100g] = 48.8 mL/100g x k2,[min-1]. Application of this 
relationship to this study yields an astrocytic CMRO2 of 0.7 mL/min/100g in rats and humans 
at baseline. This amounts to approximately 20 % of whole brain oxygen consumption (3.4 ± 
0.28 mL/min/100g in man (Kety and Schmidt 1948)).This value compares favorably to 
published values for the fraction of astrocytic ATP generation by oxidative processes (Hertz 
and Kala 2007; Hertz et al. 2007; Oz et al. 2004) which are in the range of 14 to 30 %.   
 
Is k2 specific for astrocytic metabolism? 
One important observation in this regard is that labeled acetate is only taken up by 
astrocytes and not neurons (Waniewski and Martin 1998). However, a fraction of the label 
will eventually end up in neurons as labeled glutamine/glutamate (via the 
glutamate/glutamine cycle), which was produced via the α-ketoglutarate-glutamate step in 
the astrocytes. Nevertheless, the transfer of labeled glutamine to neurons is slow relative to 
the 20 minute acquisition time of this study. Lebon et al investigated astrocytic energy 
metabolism using nuclear magnetic resonance spectroscopy and 2-13C-acetate in humans 
(Lebon et al. 2002). They concluded that the labeled glutamine/glutamate observed during 
the first 20 minutes following the start of the 2-13C-acetate infusion reflected astrocytic 
glutamate only. It therefore seems reasonable to assume that most of the 11C activity 
measured in our study was originating from astrocytes. Even if a small fraction of labeled 
glutamine/glutamate had reached the neurons, the contribution of neuronal 11C-CO2 
production could be expected to have been small. Hertz et al. (1988) demonstrated in cell 
cultures, that glutamate oxidation of neurons was at most 25 percent of the one in astrocytes. 
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In addition, recent work found a 4.3-fold higher expression of the enzyme glutamate 
dehydrogenase Glud1 in astrocytes, also suggesting a substantially higher capacity for 
astrocytes to metabolize glutamate (Lovatt et al. 2007). 
 
Comparison of the k2 method with autoradiography 
Cruz et al investigated the accumulation of 2-14C-acetate during acoustic stimulation in rats 
(Cruz et al. 2005) using autoradiography performed 5 minutes following tracer injection. They 
reported a 15-18% increase of 2-14C-acetate uptake in the stimulated compared to the 
contralateral structures. These results are in line with our experiments. At 5 minutes the 
uptake of 1-11C-acetate was 14 % higher in the stimulation compared to the baseline 
experiments (Fig. S1; supplementary data). This value was calculated by simulating tissue 
time activity curves with a mean input curve and the mean K1 and k2 values of the stimulation 
and baseline experiments. Here, it is crucial to point to an important difference in the 
methodology. By evaluating just one time-point as in autoradiographic studies, it is not easy 
to determine to what degree the differential uptake is influenced by increased blood flow, 
although this influence seems to be low for acetate (Dienel et al., 2007), but probably not 
negligible as our demonstration of a small K1 increase during stimulation suggests. To 
separate delivery and washout a kinetic approach as chosen in this study seems 
advantageous. On the other hand autoradiographic studies deliver images and, when using  
the long-lived 14C, allow an easier determination of metabolites. 
Using the short-lived isotope 11C we simply concentrated on two aspects of the label kinetics, 
delivery and washout. We cannot deliver any data concerning the fate of the label between 
these steps which may be very complex. An indication of this complexity is demonstrated in 
the model of Figure 6. Previous work by Berl et al. (1969) demonstrated a) that 5 minutes 
following injection of 1-14C-acetate most label is found in amino acids and b) that there is a 
decline of their concentration afterwards. This may indicate that most acetate oxidation 
happens indirect via amino acids. More extended information on the fate of the label are 
found elsewhere (Dienel et al. 2007; Berl and Frigyesi 1969). Nevertheless, still more studies 
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are needed to identify the contribution of acetate and TCA cycle metabolites as direct 
substrates for oxidative metabolism. 
 
General remarks 
Due to the delay of the onset of the label washout k2 is smaller during the first minutes 
following injection. This effect was not taken into account in the tracer kinetic modeling, e.g. 
k2 was assumed constant. To estimate the resulting error we calculated simulated tissue 
time-activity curves with k2 = 0 during the first 5 minutes and = 0.027 min-1 thereafter. The 
refit of these curves using a constant k2 demonstrated only a 1.5 % change of k2.  
Another point concerns parameter identifiability. The sensitivity analysis demonstrated that 
the dependence of tissue activity on k2 is more pronounced at the higher values, implying 
that the k2 values during baseline are less reliable than during stimulation. This aspect and 
the fact that k2 at baseline is relatively small may lead to a relatively large error margin in the 
ratio k2simulation/k2baseline. We also did not consider the effect of blood-borne 11C-CO2 on K1 and 
k2. Most of the CO2 in blood is converted to HCO3¯ which does not cross the blood brain 
barrier. Approximately 5 percent of total HCO3¯/CO2 is present as dissolved 11C-CO2 (Brooks 
et al. 1984) which freely penetrates the brain. We constructed simulated tissue time activity 
curves using the one-tissue compartment model and the blood-borne 11C-CO2 as a second 
input curve. K1 and k2 values for this fraction of CO2 were taken from Brooks et al. (1984). 
These tissue time activity curves were then refitted using the standard one-tissue 
compartment model not considering blood borne 11C-CO2. The deviation of the K1 and k2 
values was less than 1.5 percent, demonstrating that the effect of blood-borne 11C-CO2 on K1 
and k2 is negligible. 
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Summary 
1-11C-acetate seems a promising tracer to investigate astrocytic oxidative metabolism in 
animals and humans. If the washout rate is indeed representing the production of 11C-CO2, 
then its increase during stimulation would point to a substantially higher astrocytic oxidative 
metabolism during brain activation. However, the quantitative relationship between k2 and 
CMRO2 needs to be determined in future experiments. 
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Appendix:  
Details of beta probe experiments and human PET measurements 
 
Blood and tissue processing 
a) Physiological blood parameters 
Several blood gas variables (pH, pCO2, pO2) relevant to cerebral energy metabolism were 
measured with a pH/blood gas analyzer (AVL, Compact 3, Roche Diagnostics, Switzerland) 
before the start of tracer kinetic measurements. Plasma lactate levels were determined 
before the first tracer injection in 24 animals (Ektachem DT, Kodak, USA). In animals of 
group V (dichloroacetate challenge) lactate levels were determined twice, before and 4 hours 
after injection of dichloroacetate respectively. (Ektachem DT, Kodak, USA). In 5 animals 
there were technical problems with the analyzer rendering a measurement impossible. 
 
b) Determination of the arterial plasma input curve 
For the CBF measurements arterial blood was continuously drawn during scanning and the 
activity in the catheter was measured in a coincidence counter (GE Medical Systems) which 
was cross calibrated with the beta scintillator and the PET scanner respectively. During the 
1-11C-acetate scan arterial radioactivity was also measured online for the total scan time in 
the animal experiments (for an example of acquired time activity curves see Figure S2, 
supplementary data). In the human study it was acquired online only for the first five minutes 
so as not to miss the peak of the arterial input curve, thereafter for the remaining 15 minutes 
four single samples were taken manually at different time points (around 3, 6, 15 and 25 
minutes) and processed as described below. Whole blood activity was then corrected for a) a 
different tracer concentration in whole blood and plasma and b) the build-up of labeled 
metabolites. The ratio “11Cplasma/11Cwhole blood“ was determined in all animals at different time-
points (3 blood samples per injection). The data of all animals were then pooled and the 
time-course of the ratio was approximated by fitting a quadratic polynomial to the data. This 
function was then used to convert counts in whole blood to counts in plasma. In humans, the 
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11C concentration in whole blood (CB) was first converted to 11C concentration in plasma (CPL) 
using the same conversion function as determined in rats.  
Secondly, plasma activity was corrected for the build-up of labeled metabolites using data 
from previous 1-11C-acetate studies in the human heart (Buck et al. 1991). 
 
c) Metabolite analysis in blood 
Three blood samples (about 400 µL each) were collected at different time points during each 
20 minutes acquisition for analysis of authentic tracer and metabolites. These samples were 
first centrifuged for 3 minutes at 2000 rpm. Proteins were then precipitated with 75 µL 
acetonitrile in 50 µL plasma. After a second centrifugation for 3 minutes at 2000 rpm, the 
composition of the 11C-derived radioactivity in the supernatant (80 µL) was analyzed by high-
pressure liquid chromatography (HPLC) on a polymeric column (PRP-1, 5-µm, 250 × 4.1 mm 
i.d., Hamilton, U.S.A.) with 3 mmol/L phosphoric acid in water (pH 2.67) as the mobile phase 
(1 mL/min). The amount of authentic tracer was expressed as a fraction of total plasma 11C 
counts (f).  
The fraction data of all animals was then pooled and the time-course of the fraction was 
approximated by a decaying exponential function of the form function f = 1-α(1− exp(-µt)). 
This function was subsequently employed to convert the total plasma activity to the time-
course of authentic 1-11C-acetate (= input curve). 
 
 
Data analysis 
In the animal and human studies the analytical and statistical methods were similar as 
described below. All calculations were performed using the software package PMOD 
((Mikolajczyk et al. 1998); PMOD Technologies, Adliswil, Switzerland). 
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a) CBF measurements 
The basis of the calculation for CBF measurements was the one-tissue compartment model 
including a partition coefficient for H215O (see Figure 6A). The change of the radioactivity 
concentration in tissue CT is then defined by the following differential equation 
 
dCT/dt=CBF(CA(t)-CT(t)/p)    (1) 
 
where CA is the arterial tracer concentration and p is the tissue partition coefficient, e.g that 
fraction of tissue that is permeable for H215O. In this configuration CTISS is the concentration of 
H215O in 1 mL of brain and it is assumed that H215O immediately reaches a homogeneous 
concentration in permeable space and no division into a vascular and a tissue compartment 
is necessary. The analytical solution of (1) is  
 
CT=CBF exp (-CBF/p t)  C⊗ A    (2) 
 
where  means mathematical convolution.  ⊗
 
Equation 2 was fitted to the data using least squares fitting (Marquardt algorithm) 
implemented in the software PMOD (Mikolajczyk et al. 1998). Prior to data analysis tissue 
TACs and arterial input curves were corrected for physical decay of 15O. 
 
With the human H215O PET data we calculated quantitative parametric maps representing 
regional cerebral blood flow (rCBF) using the integration method described by Alpert (Alpert 
et al. 1984). This method yielded maps of K1 and k2 which represent rCBF and rCBF/p 
respectively (p = partition coefficient). Before calculation of the parametric maps, the input 
curve was corrected for delay and dispersion.  
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b) 1-11C-acetate experiments 
The investigated method consisted of standard compartmental modeling using an arterial 
input function. Tracer kinetic modeling was performed using the one-tissue compartment 
model depicted in Figure 6B.  
 
K1 :  describes uptake of tracer across the blood brain barrier. K1 is related to the 
first pass extraction fraction (EF) and CBF through the following equation: K1= 
EF x CBF. This equation was used to determine EF in the animal and human 
experiments. 
  
k2 :  represents back-diffusion of radioactivity from tissue to vascular space 
 
Tracer exchange between the compartments is described by the following differential 
equation 
 
      (3) 
Since the total activity measured in a region is composed of counts from tissue and blood, all 
models contained a parameter (α) correcting for blood activity. 
 
     (4) 
CVOI ty concentration in the defined 
11C activity measured by the tip 
α:  
CT: cular compartment  
bloo
 
dT i voi C C C α α +− = )1 (
       
where 
an PET study, CVOI is the 11C activi: in the hum
volume of interest, in the animal study it is the 
of the beta scintillator. 
percentage of intravascular space in tissue  
Activity in the extra vas
CB:  total blood activity 
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CT was calculated by numerical integration of the differential equations. The correction for the 
ontribution of blood in the brain (α) was fixed at 0.05 This value considers that signals 
Delay of onset of radiolabel washout 
To check whether the start of the radioactivity washout from tissue was delayed, the first 5 
were refitted with only k2 as a free parameter and K1 
 
 
Supplementary information is available at the Journal of Cerebral Blood Flow & Metabolism 
ebsite. 
c
originating from large superficial pial vessels impact the beta scintillator measurements.  
 
minutes of data following tracer injection 
fixed to the full length fit.  
 
w
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Figure legends 
 
Figure 1 
In the upper panel the time course of 11C radioactivity in whole blood (●), plasma (□) and 
brain tissue (▼) acquired over 20 minutes is shown. In addition the model fit is demonstrated 
(straight line, K1 = 0.085 ml/min/ml tissue, k2 = 0.015 min-1). The goodness-of-fit is 
demonstrated by the random distribution of the residuals, demonstrated in the insert. 
In the lower panel the fraction f of true 1-11C-acetate in plasma in animal and human studies 
is plotted. The filled circles represent data points from animal studies (anesthetized rats) and 
the solid line is the corresponding fit of the function f = 100-α(1− exp(-µt)) . Least squares 
fitting yielded α = 93 % and µ = 0.11 min-1. In the human study (open circles; conscious 
humans), α and µ were taken from previous experiments which had yielded very similar 
values (α = 91%, µ = 0.13 min-1) (Buck et al. 1991). 
 
Figure 2  
The top and middle graph demonstrate time activity curves of 11C activity in rat brain tissue 
normalized to injected activity per g bodyweight yielding standardized uptake values (SUV). 
The curves represent mean data from 5 experiments. In the baseline-baseline experiments 
(top panel) the curves appear identical. In contrast, the washout of 11C activity is remarkably 
larger during stimulation (middle panel). The bottom panel illustrates the residuals between fit 
and data if only the first 5 minutes of data are fitted. Such a short fit yields substantially lower 
initial washout rates than a 20 minute fit, demonstrating that the onset of the washout of 
radiolabel from tissue is delayed.  
 
Figure 3 
Summary of animal data. Panels A and B demonstrate the reproducibility of parameters K1 
and k2. There was no significant change of K1 and k2 between sequential baseline 
experiments. Panels C and D show the increase of K1 and k2 during infraorbital nerve 
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stimulation. The values of k2 following the administration of dichloroacetate (DAC, 50 mg/kg) 
at baseline and during infraorbital nerve stimulation are demonstrated in panel E. The p 
values were calculated using the Wilcoxon Signed Rank test. Values are given as mean ± 
SD. 
 
 
 
Figure 4 
Time-activity curves of 1-11C-acetate uptake in the human visual cortex normalized to 
injected activity per kg bodyweight yielding standardized uptake values (SUV). The curves 
represent mean data from all 6 human experiments. During visual stimulation the clearance 
of 11C activity is larger compared to baseline. Note also the modestly faster wash-in of 
radioactivity during stimulation. 
 
Figure 5  
Summary of human data. The change of CBF from baseline to visual stimulation in the 3 
examined brain areas is demonstrated in the top panels, the one of K1 and k2 of 1-11C-acetate 
in the middle and bottom panels respectively. The p values were calculated using Wilcoxon 
Signed Rank test. Values are given as mean ± SD. 
 
Figure 6 
One-tissue compartment models used in animal and human studies to analyze CBF using 
H215O (A) and the kinetics of 1-11C-acetate respectively (B). K1 describes the transfer of 
acetate from blood to tissue whereas k2 corresponds to the flux of radiolabel from tissue to 
blood. Labeled acetate in tissue (Cac-tiss) is converted to acetyl-CoA, catalyzed by acetyl-CoA 
synthetase. Acetyl-CoA then enters the TCA cycle, where the label can either be transferred 
to CO2 or metabolites (Cm-tiss) such as glutamine and glutamate which were produced via α-
keto-glutarate. Some labeled metabolites will reenter the TCA cycle at the α-keto-glutarate 
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level and in this way yield more labeled CO2. In theory, k2 denotes the backdiffusion of all 
labeled species from tissue. However, as discussed in the main text, we argue that the loss 
of label is mainly due to backdiffusion of 11C-CO2, and that the rate of this label loss, 
described by k2, is reflecting the production of CO2 and is therefore closely related to 
oxidative metabolism.  
 
Supplementary Information 
 
Supplementary Figure S1 
Tissue time activity curves are shown using a mean input curve and the mean K1 and k2 
values of the stimulation and baseline experiments in anesthetized rats respectively. Note 
the higher uptake of 1-11C-acetate (+ 14 %) after 5 minutes in the stimulation experiments. 
 
 
 
 
 
 
 
 
